Cambridge Healthtech Institute ’s 2nd Annual

Advances in Recovery and Purification

20-21 March 2019

 

As product pipelines diversify from traditonal mAbs, downstream processing teams are under increasing pressure to develop new recovery and purification platforms, while at the same time, continue to reduce timelines, costs and minimize bottlenecks for traditional mAbs therapies.

 

Cambridge Healthtech Institute’s Advances in Recovery and Purification meeting brings together industry and academia to discuss the latest developments in the capture, recovery and purification of biotherapeutics, mAb and non-mAb, with data-driven case studies on next-generation technologies and strategies in affinity chromatography, clarification, depth filtration, new membranes, flocculation, as well as DSP strategies for emerging modalities such as fragments, bispecifics, gene therapies and vaccines. How do your strategies compare?

 

Coverage will include, but is not limited to:

 

  • DSP for Next-Generations Protein Therapeutics - managing DSP across increasingly diverse portfolios, process and facilty management, emerging technologies
  • DSP for new mAb modalities - antibody variants, nanobodies, bispecifics, gene therapies, viral vectors, antibody fragments, fusion proteins
  • Alternatives to protein A - non IgG
  • Next-Generation Downstream Processing Strategies
  • Innovations at harvest step
  • HTPD and modelling for to improve process development, mechanistic modelling
  • Optimizing resin performance, new Protein A, regeneration strategy, chemical resin
  • Affinity chromatography
  • Novel chromatographic technologies
  • Depth filtration
  • Stationary to liquid phase
  • Precipitation
  • Crystallization
  • Flocculation
  • Membrane Filtration
  • Reducing impurities
  • Optimizing Existing Downstream Processes
  • Reducing the number of DSP steps
  • Digitalization to improve processes and workflows
  • Automation, HTPD, modelling and process characterization
  • Reducing impurities and contaminants
  • Removing host cell proteins
  • Viral safety

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is Friday, 24 August 2018.

 

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute  policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Daniel Barry

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-247-6266
Email: dbarry@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Sherry Johnson

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-1359
Email: sjohnson@healthtech.com

 

Companies L-Z

Carolyn Cooke

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5412
Email: ccooke@healthtech.com